We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Spark Energy (SPKE) to Post Q4 Earnings: What's in Store?
Read MoreHide Full Article
Spark Energy, Inc. is scheduled to release fourth-quarter 2019 results on Mar 5, 2020. The company has trailing four-quarter positive earnings surprise of 1,875%, on average.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
Spark Energy’s focus on adding smaller commercial and high value residential customers along with disciplined pricing across all customer segments are likely to have boosted fourth-quarter earnings. Moreover, its focus on cost savings and improvement in hedging strategies are likely to have had a positive impact on fourth-quarter performance.
The Zacks Consensus Estimate for fourth-quarter 2019 sales is pegged at $190.7 million, which indicates a decline of 16.55% from the year-ago quarter’s figure. The Zacks Consensus Estimate for fourth-quarter earnings per share (EPS) is pegged at 5 cents per share, which calls for year-over-year increase of 117.24%.
What Our Quantitative Model Predicts
Our proven model doesn’t conclusively predict an earnings beat for Spark Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here. You can seethe complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, Spark Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same industry that have reported earnings beat in the fourth quarter of 2019.
Xcel Energy Inc. (XEL - Free Report) posted fourth-quarter 2019 operating earnings of 56 cents per share, which beat the Zacks Consensus Estimate of 53 cents by 5.6%.
Pinnacle West Capital Corporation (PNW - Free Report) delivered adjusted EPS of 57 cents in the fourth quarter of 2019, which beat the Zacks Consensus Estimate of 47 cents by 21.3%.
FirstEnergy Corporation (FE - Free Report) delivered fourth-quarter 2019 operating earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 48 cents by 14.6%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Spark Energy (SPKE) to Post Q4 Earnings: What's in Store?
Spark Energy, Inc. is scheduled to release fourth-quarter 2019 results on Mar 5, 2020. The company has trailing four-quarter positive earnings surprise of 1,875%, on average.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
Spark Energy’s focus on adding smaller commercial and high value residential customers along with disciplined pricing across all customer segments are likely to have boosted fourth-quarter earnings. Moreover, its focus on cost savings and improvement in hedging strategies are likely to have had a positive impact on fourth-quarter performance.
Spark Energy, Inc. Price and EPS Surprise
Spark Energy, Inc. price-eps-surprise | Spark Energy, Inc. Quote
Q4 Expectation
The Zacks Consensus Estimate for fourth-quarter 2019 sales is pegged at $190.7 million, which indicates a decline of 16.55% from the year-ago quarter’s figure. The Zacks Consensus Estimate for fourth-quarter earnings per share (EPS) is pegged at 5 cents per share, which calls for year-over-year increase of 117.24%.
What Our Quantitative Model Predicts
Our proven model doesn’t conclusively predict an earnings beat for Spark Energy this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: The company’s Earnings ESP is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Currently, Spark Energy carries a Zacks Rank #3.
Stocks to Consider
Investors can consider the following players from the same industry that have reported earnings beat in the fourth quarter of 2019.
Xcel Energy Inc. (XEL - Free Report) posted fourth-quarter 2019 operating earnings of 56 cents per share, which beat the Zacks Consensus Estimate of 53 cents by 5.6%.
Pinnacle West Capital Corporation (PNW - Free Report) delivered adjusted EPS of 57 cents in the fourth quarter of 2019, which beat the Zacks Consensus Estimate of 47 cents by 21.3%.
FirstEnergy Corporation (FE - Free Report) delivered fourth-quarter 2019 operating earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 48 cents by 14.6%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>